A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. Cook. [electronic resource]
Producer: 20110824Description: er2 p. digitalISSN:- 1937-9145
- Benzimidazoles
- Cell Cycle -- drug effects
- Cell Death -- drug effects
- Cell Line, Tumor
- Colorectal Neoplasms -- drug therapy
- Drug Resistance, Neoplasm -- genetics
- Gene Amplification
- Genes, ras
- Humans
- MAP Kinase Signaling System -- drug effects
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Phosphoinositide-3 Kinase Inhibitors
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins B-raf -- genetics
- Proto-Oncogene Proteins p21(ras)
- Up-Regulation
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Corrected and Republished Article
There are no comments on this title.
Log in to your account to post a comment.